Clinical trial
Proof of Concept Study of Eurartesim® in Patients With Imported Uncomplicated Plasmodium Vivax Malaria
NCT02110784 is registered in ClinicalTrials.gov with Alfasigma S.p.A. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Proof of Concept Study of Eurartesim® in Patients With Imported Uncomplicated Plasmodium Vivax Malaria
- Lead sponsor
- Alfasigma S.p.A.
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- June 18, 2014
- Completion date
- April 30, 2017
- Enrollment
- 27 (actual)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.